SpyGlass Pharma, a late-stage biopharmaceutical company focused on chronic eye conditions, announced its executive team will participate in three upcoming investor conferences: Stifel Healthcare Conference on Nov 12 in New York, Jefferies Global Healthcare Conference on Nov 17 in London, and Citi’s Global Healthcare Conference on Dec 3 in Miami. These events will feature fireside chats and one-on-one meetings, with live webcasts available on the company’s website. SpyGlass Pharma aims to advance long-acting drug delivery technologies for eye diseases, enhancing patient care and vision preservation.
SpyGlass Pharma's upcoming investor conference participation is noted here with Pluang's Health-sector market data as of Nov 05, 2026 19:42 WIB: Of 150 priced US Health-sector stocks on Pluang, 87 rose and 56 fell today. Notable movers include LFST at USD 14.99 with a 5.49% increase and NVAX at USD 11.21 with a 5.31% gain, where NVAX also shows a strong buy order activity of 84%.
Global tech giants like Amazon, Google, and Microsoft are committing hundreds of billions of dollars to expand AI-focused data center accelerators, driven by surging demand from generative AI workloads that exceed traditional CPU capabilities. These ...
Berkshire Hathaway's stock portfolio is now worth about three times what the company originally paid for it. These gains alone represent roughly 19% of Berkshire Hathaway's total company value, highlighting the significant growth and value generated ...
C3is Inc. will implement a one-for-five reverse stock split effective November 9, 2026, reducing its outstanding shares from about 4.2 million to 0.84 million. This move aims to increase the stock price to meet Nasdaq's minimum bid price requirement ...
Firmly secured $15 million in a Series A funding round led by Squarepoint Capital, with participation from J.P. Morgan Payments, Mastercard, and Samsung NEXT. The company provides a no-code platform that connects merchants to AI-driven shopping chann...
On November 4, 2026, Shell plc repurchased a total of 1,876,276 shares across multiple trading venues including LSE, Chi-X, BATS, XAMS, CBOE, and TQEX. The shares were bought at prices ranging from £37.98 to £38.82 and €45.70 to €46.72, with an avera...
